For the quarter ending 2025-09-30, CVSI made $3,256K in revenue. -$382K in net income. Net profit margin of -11.73%.
| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Product sales, net | 3,256 | 3,606 | 3,947 | 3,865 |
| Cost of goods sold | 1,677 | 1,948 | 2,150 | 2,087 |
| Gross profit | 1,579 | 1,658 | 1,797 | 1,778 |
| Research and development | 24 | 30 | 30 | 29 |
| Selling, general and administrative | 1,830 | 2,139 | 2,383 | 2,090 |
| Benefit from reversal of accrued payroll taxes | 0 | -522 | - | - |
| Total operating expenses | 1,854 | 1,647 | 2,413 | 2,119 |
| Operating loss | -275 | 11 | -616 | -341 |
| Other expense, net | - | -151 | -32 | -115 |
| Gain on extinguishment of debt | 0 | 38 | - | - |
| Interest expense, net | 107 | - | - | - |
| Loss before income taxes | -382 | -102 | -649 | -456 |
| Income tax expense | 0 | 7 | -2 | - |
| Net loss | -382 | -109 | -646 | -456 |
| Earnings per share, basic | 0 | 0 | -0.003 | 0 |
| Earnings per share, diluted, total | 0 | 0 | -0.003 | 0 |
| Weighted average common shares outstanding, basic (in shares) | 184,264,000 | 184,264,000 | -2,225,333.333 | 182,261,000 |
| Weighted average common shares outstanding, diluted (in shares) | 184,264,000 | 184,264,000 | -2,225,333.333 | 182,261,000 |
CV Sciences, Inc. (CVSI)
CV Sciences, Inc. (CVSI)